We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Fresenius SE and Company KGaA (PK) | USOTC:FSNUY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.112 | -1.48% | 7.4405 | 7.32 | 7.63 | 7.53 | 7.4405 | 7.53 | 44,836 | 21:23:30 |
From Jun 2019 to Jun 2024
By Cecilia Butini
Fresenius SE & Co KGaA said Tuesday that its infusion and transfusion subsidiary Fresenius Kabi AG is expanding its Austrian facilities with an investment of 60 million euros ($72.31 million).
The investment, which will run through 2023, will focus on expanding capacity as well as an upgrade of infrastructure at Fresenius Kabi's production plant in Graz and at a packing center in Werndorf, the company said.
It added that the number of jobs the expansion will create, in addition to the existing 900 in Graz, cannot yet be determined.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
February 09, 2021 05:43 ET (10:43 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Fresenius SE and Company... (PK) Chart |
1 Month Fresenius SE and Company... (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
